Acute Coronary Syndrome Market by Type (Non-St-Elevation Myocardial Infarction (NSTEMI), St-Elevation Myocardial Infarction (STEMI), Unstable Angina), Offering (Blood Tests, Imaging, Stress Test), End User - Global Forecast 2024-2030
The Acute Coronary Syndrome Market size was estimated at USD 1.82 billion in 2023 and expected to reach USD 1.94 billion in 2024, at a CAGR 6.76% to reach USD 2.89 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Acute Coronary Syndrome Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute Coronary Syndrome Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Acute Coronary Syndrome Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Baxter International, Inc., Bayer AG, bioMérieux SA, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Johnson & Johnson Service, Inc., Koninklijke Philips N.V., Medtronic PLC, Merck & Co, Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Siemens AG, Terumo Corporation, and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Acute Coronary Syndrome Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Non-St-Elevation Myocardial Infarction (NSTEMI)
Blood Tests
Academic Institutes
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Acute Coronary Syndrome Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute Coronary Syndrome Market?
- What are the technology trends and regulatory frameworks in the Acute Coronary Syndrome Market?
- What is the market share of the leading vendors in the Acute Coronary Syndrome Market?
- Which modes and strategic moves are suitable for entering the Acute Coronary Syndrome Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Acute Coronary Syndrome Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of cardiovascular diseases worldwide
- 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
- 5.1.1.3. Rise in drug discovery and drug development process
- 5.1.2. Restraints
- 5.1.2.1. High cost of treatment of acute-coronary-syndrome
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in the treatment of acute-coronary-syndrome
- 5.1.3.2. Ongoing R&D for development of enhanced diagnostic devices and treatment for acute-coronary-syndrome
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulatory requirement for approval of drugs and devices for acute-coronary-syndrome treatment
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Acute Coronary Syndrome Market, by Type
- 6.1. Introduction
- 6.2. Non-St-Elevation Myocardial Infarction (NSTEMI)
- 6.3. St-Elevation Myocardial Infarction (STEMI)
- 6.4. Unstable Angina
- 7. Acute Coronary Syndrome Market, by Offering
- 7.1. Introduction
- 7.2. Blood Tests
- 7.3. Imaging
- 7.4. Stress Test
- 8. Acute Coronary Syndrome Market, by End User
- 8.1. Introduction
- 8.2. Academic Institutes
- 8.3. Diagnostic Centers
- 8.4. Hospitals & Clinics
- 9. Americas Acute Coronary Syndrome Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Acute Coronary Syndrome Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Acute Coronary Syndrome Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Amgen Inc.
- 13.1.3. AstraZeneca PLC
- 13.1.4. Baxter International, Inc.
- 13.1.5. Bayer AG
- 13.1.6. bioMérieux SA
- 13.1.7. Boehringer Ingelheim International GmbH
- 13.1.8. Boston Scientific Corporation
- 13.1.9. DAIICHI SANKYO COMPANY, LIMITED
- 13.1.10. Dr. Reddy’s Laboratories Ltd.
- 13.1.11. Eli Lilly and Company
- 13.1.12. F. Hoffmann-La Roche Ltd.
- 13.1.13. Gilead Sciences, Inc.
- 13.1.14. Johnson & Johnson Service, Inc.
- 13.1.15. Koninklijke Philips N.V.
- 13.1.16. Medtronic PLC
- 13.1.17. Merck & Co, Inc.
- 13.1.18. Novartis AG
- 13.1.19. Pfizer Inc.
- 13.1.20. Regeneron Pharmaceuticals Inc.
- 13.1.21. Sanofi S.A.
- 13.1.22. Siemens AG
- 13.1.23. Terumo Corporation
- 13.1.24. Teva Pharmaceutical Industries Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ACUTE CORONARY SYNDROME MARKET RESEARCH PROCESS
- FIGURE 2. ACUTE CORONARY SYNDROME MARKET SIZE, 2023 VS 2030
- FIGURE 3. ACUTE CORONARY SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ACUTE CORONARY SYNDROME MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ACUTE CORONARY SYNDROME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ACUTE CORONARY SYNDROME MARKET DYNAMICS
- FIGURE 7. ACUTE CORONARY SYNDROME MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ACUTE CORONARY SYNDROME MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ACUTE CORONARY SYNDROME MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
- FIGURE 10. ACUTE CORONARY SYNDROME MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ACUTE CORONARY SYNDROME MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. ACUTE CORONARY SYNDROME MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ACUTE CORONARY SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ACUTE CORONARY SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ACUTE CORONARY SYNDROME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ACUTE CORONARY SYNDROME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ACUTE CORONARY SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ACUTE CORONARY SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACUTE CORONARY SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ACUTE CORONARY SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ACUTE CORONARY SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook